Loading clinical trials...
Loading clinical trials...
This the first-in-human (FIH) study for the Investigational Medicinal Product (IMP) EP102, is designed to explore the maximum tolerated dose (MTD), the overall safety profile, its pharmacokinetic (PK)...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Epics Therapeutics
NCT07123415 · Advanced Solid Cancer, Advanced Solid Tumor (Phase 1)
NCT07434609 · Advanced Solid Tumor (Phase 1)
Institut Jules Bordet
Brussels
Cliniques universitaires Saint-Luc
Brussels
Masaryk Memorial Cancer Institute
Brno
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions